Integral Health Asset Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-100,000
Closed -$2.86M 78
2025
Q2
$2.86M Sell
100,000
-50,000
-33% -$1.49M 0.27% 67
2025
Q1
$4.95M Buy
+150,000
New +$4.89M 0.55% 52
2024
Q2
Sell
-250,000
Closed -$6.77M 76
2024
Q1
$6.77M Buy
250,000
+1,000
+0.4% +$28.4K 0.66% 60
2023
Q4
$6.91M Sell
249,000
-26,000
-9% -$675K 1% 49
2023
Q3
$7.7M Sell
275,000
-9,000
-3% -$264K 1.09% 39
2023
Q2
$8.89M Buy
284,000
+105,000
+59% +$3.18M 1.17% 38
2023
Q1
$5.05M Buy
+179,000
New +$4.88M 1.05% 40
2022
Q4
Sell
-200,000
Closed -$4.47M 63
2022
Q3
$4.47M Sell
200,000
-61,966
-24% -$1.61M 0.91% 45
2022
Q2
$7.8M Buy
261,966
+11,966
+5% +$344K 1.61% 21
2022
Q1
$6.58M Buy
250,000
+200,000
+400% +$4.95M 1.71% 22
2021
Q4
$1.16M Buy
+50,000
New +$1.31M 0.32% 63
2021
Q3
Sell
-150,000
Closed -$3.68M 73
2021
Q2
$3.68M Buy
+150,000
New +$3.34M 1.01% 40
2020
Q2
Sell
-150,000
Closed -$2.16M 62
2020
Q1
$2.16M Buy
+150,000
New +$2.68M 0.96% 38

Other funds holding ALKS